Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-7-8
pubmed:abstractText
Immunocompromised persons infected with Mycobacterium tuberculosis (MTB) have increased risk of tuberculosis (TB) reactivation, but their management is hampered by the occurrence of false-negative results of the tuberculin skin test (TST). The T-cell interferon (IFN)-gamma release blood assays T-SPOT.TB (TS.TB) [Oxford Immunotec; Abingdon, UK] and QuantiFERON-TB Gold In-Tube (QFT-IT) [Cellestis Ltd; Carnegie, VIC, Australia] might improve diagnostic accuracy for latent TB infection (LTBI) in high-risk persons, although their performance in different groups of immunocompromised patients is largely unknown.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1931-3543
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
198-204
pubmed:meshHeading
pubmed-meshheading:19318676-Adult, pubmed-meshheading:19318676-Aged, pubmed-meshheading:19318676-Aged, 80 and over, pubmed-meshheading:19318676-Female, pubmed-meshheading:19318676-HIV Infections, pubmed-meshheading:19318676-Hematologic Neoplasms, pubmed-meshheading:19318676-Humans, pubmed-meshheading:19318676-Immunocompromised Host, pubmed-meshheading:19318676-Liver Failure, pubmed-meshheading:19318676-Liver Transplantation, pubmed-meshheading:19318676-Male, pubmed-meshheading:19318676-Middle Aged, pubmed-meshheading:19318676-Mycobacterium tuberculosis, pubmed-meshheading:19318676-Predictive Value of Tests, pubmed-meshheading:19318676-Reproducibility of Results, pubmed-meshheading:19318676-Tuberculin Test, pubmed-meshheading:19318676-Tuberculosis, pubmed-meshheading:19318676-Virus Latency, pubmed-meshheading:19318676-Young Adult
pubmed:year
2009
pubmed:articleTitle
Performance of tests for latent tuberculosis in different groups of immunocompromised patients.
pubmed:affiliation
Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Italy. luca.richeldi@unimore.it
pubmed:publicationType
Journal Article, Comparative Study, Controlled Clinical Trial